Evidence map›Paper›PMID 27243975›Full record

ArticlePloS one2016

HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization.

Qiang Chen, Jun-Jie Bei, Chuan Liu, Shi-Bin Feng, Wei-Bo Zhao, Zhou Zhou, Zheng-Ping Yu, Xiao-Jun Du, Hou-Yuan Hu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Current research on the role of HIF in intervertebral disc degeneration.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  2. Macrophages as key modulators of calcific aortic valve disease.Frontiers in cardiovascular medicine · 2025
    Review
  3. Article
  4. Review
  5. Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease.International journal of biological sciences · 2023
    Review
  6. Review
  7. Review
  8. Matrix Vesicles as a Therapeutic Target for Vascular Calcification.Frontiers in cell and developmental biology · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Qiang ChenDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Jun-Jie BeiDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Chuan LiuDepartment of Occupational Health, Faculty of Preventive Medicine, Third Military Medical University, Chongqing, China.
Shi-Bin FengDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Wei-Bo ZhaoDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Zhou ZhouDepartment of Occupational Health, Faculty of Preventive Medicine, Third Military Medical University, Chongqing, China.
Zheng-Ping YuDepartment of Occupational Health, Faculty of Preventive Medicine, Third Military Medical University, Chongqing, China.
Xiao-Jun DuExperimental Cardiology, Baker IDI Heart and Diabetes Institute, and Central Clinical School, Monash University, Melbourne, Australia.
Hou-Yuan HuDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Army Medical University · CNBaker Heart and Diabetes Institute · AUNaval University of Engineering · CNSouthwest Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous clinical conditions have been linked to ectopic mineralization (EM). This process of pathological biomineralization is complex and not fully elucidated, but thought to be started within matrix vesicles (MVs). We hypothesized that high mobility group box 1 (HMGB1), a cytokine associated with biomineralizing process under physiological and pathological conditions, induces EM via promoting MVs secretion from macrophages. In this study, we found that HMGB1 significantly promoted secretion of MVs from macrophages and subsequently led to mineral deposition in elevated Ca/Pi medium in vitro. Transmission electron microscopy of calcifying MVs showed formation of hydroxyapatite crystals in the vesicle interior. Subcutaneous injection into mice with MVs derived from HMGB1-treated cells showed a greater potential to initiate regional mineralization. Mechanistic experiments revealed that HMGB1 activated neutral sphingomyelinase2 (nSMase2) that involved the receptor for advanced glycation end products (RAGE) and p38 MAPK (upstream of nSMase2). Inhibition of nSMase2 with GW4869 or p38 MAPK with SB-239063 prevented MVs secretion and mineral deposition. Collectively, HMGB1 induces MVs secretion from macrophages at least in part, via the RAGE/p38 MAPK/nSMase2 signaling pathway. Our findings thus reveal a novel mechanism by which HMGB1 induces ectopic mineralization.

Indexed as

AnimalsCalcification, PhysiologicCell LineDurapatiteEnzyme ActivationExtracellular VesiclesHMGB1 ProteinImidazolesMacrophagesMaleMiceMice, Inbred C57BLMicroscopy, Electron, Transmissionp38 Mitogen-Activated Protein KinasesPyrimidinesReceptor for Advanced Glycation End ProductsAger protein, mouseDurapatiteHMGB1 ProteinHMGB1 protein, mouseImidazolesp38 Mitogen-Activated Protein KinasesPyrimidinesReceptor for Advanced Glycation End ProductsRNA, Small InterferingSB 239063Smpd3 protein, mouseSphingomyelin PhosphodiesteraseTlr2 protein, mouseTlr4 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID27243975
PMCPMC4887028
OpenAlexW2416595322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.